Development Phase 3 definition

Development Phase 3 means the development of Building B on Zoning Lot 1 and the Waterfront Zoning Lot Phasing: Phase 2 in accordance with the Development Plans, Waterfront Public Access Area Plans and Waterfront Zoning Lot Phasing Plans.
Sample 1Sample 2

Examples of Development Phase 3 in a sentence

  • The Company, PTT Tank, and CHEC, together under the name of GPC Consortium, participated in the bidding of Port Authority of Thailand’s Laem Chabang Port Development Phase 3 project (Terminal F).

  • A resolution approving a Preliminary Planned Unit Development Special Exceptions Permit for a proposed Planned Unit Development, known as the Stringers Ridge Planned Unit Development, Phase 3, on tracts of land located in the 1000 block of Purple Hill Drive, more particularly described herein and as shown on the map and drawing attached hereto and made a part hereof by reference, subject to certain conditions.

  • Development Phase 3: 29,000 square metres, including a minimum of 550 square metres of non-residential Gross Floor Area required to be provided on the ground floor of the building.

  • The A/E's services shall consist of some or all of the following six (6) principal phases in accordance with this Agreement and Exhibit 1-Scope of Services and shall include the A/E’s final negotiated price proposal: (1) Schematic Design Phase, (2) Design Development Phase, (3) Construction Documents Phase, (4) Bidding Phase, (5) Construction Phase and (6) Post Construction Phase (hereinafter collectively referred to as “Design Phases”).

  • Prior to issuance of an above grade building permit for Development Phase 3, the owner shall convey a public access easement over the open space adjacent to Cordova Avenue to the satisfaction of the Chief Planner and Executive Director, City Planning and the City Solicitor to facilitate access over the lands to the pedestrian connection to Islington Avenue.

  • Gulf MTP is the developer and operator of Map Ta Phut Industrial Port Development Phase 3 Project (Phase 1) located in Map Ta Phut Industrial Estate, Rayong province, under a 35-year Public– Private Partnership (PPP) contract with IEAT.

  • Gulf MTP is the developer and operator of Map Ta Phut Industrial Port Development Phase 3 Project (Phase 1) located in Map Ta Phut Industrial Estate, Rayong province, under a 35-year Public– Private Partnership (PPP) contract with Industrial Estate Authority of Thailand.

  • The City Council of the City of Star, Idaho will hear comments from the public concerning the Amazon Falls Development Phase #3 Development Agreement Modification.

  • Development Phase 3: 102 metres; and the minimum separation distance between the building face of Tower Elements shall be 30 metres.

  • The A/E’s services shall consist of five (5) separable principal phases, (1) Schematic Design, (2) Design Development Phase, (3) Construction Documents Phase, (4) Bidding Phase and (5) Construction Phase.

Related to Development Phase 3

  • Development Phase means the period before a vehicle type is type approved.

  • Development Program means the implementation of the development plan.

  • Development Project means a project for the development of land within a

  • Development Plan has the meaning set forth in Section 3.2.

  • Development Work means the work of development to be performed on or with respect to the Land (including, without limitation, the installation of utilities, roads and all related on-site and off-site improvements) in connection with the development of the Land for the subsequent construction thereon of Homes, all of which work and construction shall be completed by or on behalf of the Borrower in accordance with the Plans and Specifications, but shall not include the Construction Improvements.

  • Development Site means any parcel or lot on which exists or which is intended for building development other than the following:

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Phase III Study means a human clinical trial that is prospectively designed to demonstrate statistically whether a product is safe and effective for use in humans in a manner sufficient to obtain regulatory approval to market such product in patients having the disease or condition being studied as described in 21 C.F.R. § 312.21(c) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Development Activities means any activity, including the discharge of dredged or fill material, which results directly in a more than de minimus change in the hydrologic regime, bottom contour, or the type, distribution or diversity of hydrophytic vegetation, or which impairs the flow, reach, or circulation of surface water within wetlands or other waters;

  • Development Area means that area to which a development plan is applicable.

  • Development Works means the external development works and internal development works on immovable property;

  • Phase III Clinical Study means a human clinical study of a product on a sufficient number of subjects that is designed to establish that such product is safe and efficacious for its intended use, and to determine warnings, precautions, and adverse reactions that are associated with such product in the dosage range to be prescribed, which trial is intended to support Regulatory Approval of such product, as described in 21 C.F.R. 312.21(c). 1.185. [***] 1.186. [***]

  • Phase I Clinical Trial means a clinical trial conducted in healthy humans or patients, which clinical trial is designed to establish the safety, drug-drug interactions and/or pharmacokinetics of an investigational drug given its intended use, and to support continued testing of such drug in Phase II Clinical Trials.

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Development Activity means any activity defined as Development which will necessitate a Floodplain Development Permit. This includes buildings, structures, and non-structural items, including (but not limited to) fill, bulkheads, piers, pools, docks, landings, ramps, and erosion control/stabilization measures.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Development Term means the period commencing on the Closing Date and ending on the earlier of (a) the Option Closing Date or (b) the date the Option terminates or expires other than by exercise.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Research Project means a discrete scientific endeavor to answer a research question or a set of research questions related to medical marijuana and is required for a medical marijuana research license.

  • Phase III Trial means a Clinical Trial of an investigational product in subjects that incorporates accepted endpoints for confirmation of statistical significance of efficacy and safety with the aim to generate data and results that can be submitted to obtain Regulatory Approval as described in 21 C.F.R. 312.21(c), or a comparable Clinical Trial prescribed by the relevant Regulatory Authority in a country other than the United States.

  • Development Application means the development application identified in Item 5 of Schedule 1 and includes all plans, reports models, photomontages, material boards (as amended supplemented) submitted to the consent authority before the determination of that Development Application.

  • Development Period means the period from the date of this Agreement until the Appointed Date;